---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-007993"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2024-01-30T23:59:59+00:00"
generated_at: "2026-06-06T14:40:53.181663+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cyclacel terminates CMO Mark Kirschbaum; appoints board member Brian Schwartz as interim CMO

## Summary
- Employment of Mark H. Kirschbaum, M.D. as Chief Medical Officer terminated effective January 25, 2024; no severance benefits.
- Dr. Brian Schwartz, a board member, appointed interim CMO effective immediately; will not be independent while serving.
- Kirschbaum eligible for COBRA health continuation; other benefits end January 31, 2024 if not elected.

## SEC filing metadata
- accession: 0001104659-24-007993
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2024-01-30T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000110465924007993/0001104659-24-007993-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000110465924007993/tm244458d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-007993
- JSON: https://secwatch.observer/filing/0001104659-24-007993.json
- Plain text: https://secwatch.observer/filing/0001104659-24-007993.txt

## Key facts
- Executive change
  Mark H. Kirschbaum departed as Chief Medical Officer at Bio Green Med Solution, Inc..
  - Action: departure
  - Role: Chief Medical Officer
  source text: the employment of Mark H. Kirschbaum, M.D. as Chief Medical Officer of Cyclacel Pharmaceuticals, Inc. (the “Company”) was terminated by the Company, effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1130166/000110465924007993/0001104659-24-007993-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.